Tag: Analytics


Biopharmaceuticals: A Look Into the Near Future

June 30, 2021

Via: David Dickson

In 1982, the U.S. approved human insulin—the first ever recombinant biopharmaceutical drug. Since then, biopharma development has proceeded at an exponential pace, with new innovations redefining, over and over again, the possibilities of medicine.  Going forward, biopharma will demand more […]